CD47 and neoplasm: In summary, in the current study, we provide preclinical evidence that CD47 blockade combined with chemotherapy significantly enhanced macrophage phagocytosis of ES cells in vitro and significantly decreased ES xenograft tumor growth and metastasis in vivo.